GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nippon Shinyaku Co Ltd (TSE:4516) » Definitions » Cash And Cash Equivalents

Nippon Shinyaku Co (TSE:4516) Cash And Cash Equivalents : 円58,094 Mil (As of Mar. 2024)


View and export this data going back to 1962. Start your Free Trial

What is Nippon Shinyaku Co Cash And Cash Equivalents?

Nippon Shinyaku Co's quarterly cash and cash equivalents declined from Sep. 2023 (円62,855.00 Mil) to Dec. 2023 (円57,323.00 Mil) but then increased from Dec. 2023 (円57,323.00 Mil) to Mar. 2024 (円58,094.00 Mil).

Nippon Shinyaku Co's annual cash and cash equivalents declined from Mar. 2022 (円60,566.00 Mil) to Mar. 2023 (円60,047.00 Mil) and declined from Mar. 2023 (円60,047.00 Mil) to Mar. 2024 (円58,094.00 Mil).


Nippon Shinyaku Co Cash And Cash Equivalents Historical Data

The historical data trend for Nippon Shinyaku Co's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nippon Shinyaku Co Cash And Cash Equivalents Chart

Nippon Shinyaku Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cash And Cash Equivalents
Get a 7-Day Free Trial Premium Member Only Premium Member Only 43,583.00 57,883.00 60,566.00 60,047.00 58,094.00

Nippon Shinyaku Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash And Cash Equivalents Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 60,047.00 55,251.00 62,855.00 57,323.00 58,094.00

Nippon Shinyaku Co Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.


Nippon Shinyaku Co  (TSE:4516) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.


Nippon Shinyaku Co Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Nippon Shinyaku Co's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.


Nippon Shinyaku Co (TSE:4516) Business Description

Traded in Other Exchanges
Address
14, Nishinosho-Monguchi-cho, Kisshoin, Minami-ku, Kyoto, JPN, 601-8550
Nippon Shinyaku Co Ltd is a specialty and generic drug manufacturing company. Nippon's research and development activities include a focus on pharmaceuticals, nutraceuticals, safety and pharmacokinetics of drug seeds, genomic drug discovery, and nucleic acid drugs. The company also develops health food ingredients, preservatives, protein preparations, and spices. Nippon considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Nippon Shinyaku Co (TSE:4516) Headlines

No Headlines